Tarsa Therapeutics

Developer of oral treatment for postmenopausal osteoporosis

placePhiladelphia, Pennsylvania, United States calendar_todayFounded 2009 groups2 employees language tarsatherapeutics.com

Registered entities

Innovation

1 patent family — focus: Human necessities; filing pace dormant. Cited 13 times.

YearFilings
20181
20191

Investor mix

7 investors on record; lead investors include Quaker Partners, Novo Holdings, MVM, Foresite Capital.

Investor typeCountShare
Venture capital229%
Private equity114%
Bank & private debt114%
Other / undisclosed343%
Coming soon